The Global Fractional Flow Reserve (FFR) Market to Reach $1.4 Billion by 2027. Next-Gen Non-Invasive Technologies Revolutionizing the Market- Arizton

According to Arizton’s latest research report, the global fractional flow reserve (FFR) market is expected to grow at a CAGR of 12% during 2022-2027. Fractional Flow Reserve (FFR) is considered the gold standard in determining the hemodynamic significance of coronary artery disease lesions. Despite encouragement and more benefits, the use of FFR is limited because it requires the use of vasodilator drugs, such as adenosine, which can increase procedure time, costs, and patient discomfort. However, the next-generation products have changed the scenario for patients and end-users. Key players such as HeartFlow are working on the technology to innovate new products for the market.

For Instance, HeartFlow plaque Technology provides plaque volume and characterizes the type of plaque present. The HeartFlow FFR CT analysis is commercially available in the US, UK, Canada, Europe, and Japan. By adding anatomical assessment and plaque scoring to the physiological information currently provided by HeartFlow FFR CT Analysis, physicians will have a better understanding and support efficient risk stratification of the burden of coronary artery disease in patients who are at increased risk of developing a heart attack.

Acist Medical Systems, a Bracco Group Company, launched its ACIST RXi Mini System, the next-generation system of its RXi Rapid Exchange FFR System. The RXi Mini is designed to provide FFR measurements to complement angiography, provide a qualitative assessment of lesion severity, and inform intervention strategy in both diagnosis and treatment of coronary and peripheral artery disease.

Fractional Flow Reserve Market Report Scope

Report Attributes Details
MARKET SIZE (2027)  $734.91 Million
MARKET SIZE (2021) $1.4 Billion
CAGR (2021-2027) 12.34%
BASE YEAR 2021
FORECAST YEAR 2022-2027
MARKET SEGMENTS Technology (Invasive and Non-Invasive), Application (Single-Vessel, and Multi-Vessel), End-User (Hospitals & Specialty Cardiac Centers, Office-Based Labs, Diagnostic Imaging Centers, and Others), and Geography
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa

 

Click Here to Download the Free Sample Report

The global fractional flow reserve (FFR) market is one of the niches and specialized segments of the global cardiovascular devices market. The market is growing significantly and is expected to grow at a similar pace during the forecast period. This surge in growth is attributable to the growing prevalence/incidence of coronary artery disease  (CADs). The prevalence of CAD has increased significantly over the last few years across the globe, creating opportunities in the market.

Key Highlights

  1. The global fractional flow reserve market would realize an absolute growth of over 101.04% in terms of revenue between the forecast period of 2021 and 2027.
  2. The increase in the prevalence of cardiovascular diseases will drive the usage of FFR in the market. Changes in lifestyle reduced physical activity and increased westernized food style have increased the number of people suffering from various cardiovascular diseases. Coronary Artery diseases are one of the largest causes of mortality across the globe.
  3. New technologies may replace the traditional pressure wires and adenosine to assess FFR. This includes image-derived FFR, such as non-invasive computed tomography imaging derived FFR (FFR-CT), and X-ray angiography derived FFR (FFR-angio) that can be performed while the patient is on the table in the cath lab.
  4. Among technology segments, the non-invasive segment dominated the global fractional flow reserve market with a share of 51.23%, followed by invasive with 48.77% in 2021.
  5. The increased technological advancements in the market and increased end-user benefits will drive the FFR market. Companies are also mainly investing in research & development to introduce the product into the market.
  6. The fractional flow reserve method can be used to treat both single and multi-vessel coronary artery disease. In 2021, the single-vessel segment dominated the global fractional flow reserve market with 52.67 percent, followed by the multi-vessel sector with 47.33 percent.
  7. The FFR market is segmented into hospitals & specialty cardiac centers, office-based labs, diagnostic imaging centers, and others. The hospitals & specialty cardiac centers segment dominated the global FFR market with a share of 41.40%, followed by office-based labs, diagnostic imaging centers, and others with 29.42%, 22.22%, and 6.97% in 2021, respectively. Arizton predicts that the office-based labs segment will likely witness the highest CAGR of 13.56% during the forecast period.

Fractional Flow Reserve Market Segmentation

Segmentation by Technology

  • Invasive
  • Non-Invasive

Segmentation by Applications

  • Single-Vessel
  • Multi-Vessel

Segmentation by End-Users

  • Hospitals & Specialty Cardiac Centers
  • Office-Based Labs
  • Diagnostic Imaging Centers
  • Others

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia

Why North American Region Gaining Momentum?

The market for the FFR is growing, due to the increase in the prevalence of cardiovascular diseases in both the US and Canada. During the epidemiologic transition from rural to industrial in the US and Canada, nutritional deficiencies and infectious diseases made way for degenerative diseases such as CVDs and cancer. The overall economic burden of CVDs continues to be high and growing in the US and Canada. Every year, millions of patients experience symptoms potentially associated with coronary artery diseases. As both the US and Canadian populations are aging, and the diagnosis rate for CVDs is also increasing, the overall burden of coronary artery disease is expected to increase in the future. North America has gained the largest share of the market, owing to the rising number of MI endovascular procedures such as PCI for treating a variety of CVDs. The availability of modern healthcare infrastructure, constant technical breakthroughs, and increased acceptance of advanced technologies are all contributing to the increase in the number of surgeries. The rising prevalence of vascular disorders is also a major driver of market expansion.

How are the Players Sustaining their Market Position in the Market?

The global fractional flow reserve (FFR) market is highly consolidated, with a small number of competitors controlling a large portion of the industry. The market is dominated by major companies. Even though new entrants have tremendous growth potential, the market is controlled by major competitors, and numerous exploratory and small med-tech startups are developing revolutionary products and technology. The limited number of players in the market is a sign of low competition for FFR products. Though clinical studies have witnessed that FFR products are more accurate in measurement, companies are focusing on alternative technologies. Technological advances and next-generational development in FFR products are augmenting the non-invasive technology segment over invasive. According to the current scenario, the FFR market is yet to reach maturity and is open with a broad range of opportunities for the market players.

Key Vendors

  • Abbott
  • ACIST Medical Systems
  • Boston Scientific
  • CathWorks
  • General Electric Company
  • Koninklijke Philips
  • Opsens
  • Siemens Healthineers

Table of Content

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.1.3 Market Estimation Caveats

4.2 Base Year

4.3 Scope of The Study

4.3.1 Market by Technology

4.3.2 Market by Applications

4.3.3 Market by End-User

4.3.4 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at A Glance

7 Introduction

7.1 Overview

7.1.1 Cad Diagnosis

7.2 FFR: An Overview

8 Market Opportunities & Trends

8.1 Next-Gen Devices Augmenting Non-Invasive FFR Methods

8.2 FFR-Oct Improving Outcomes in Diabetic Patients

8.3 AI & ML Revolutionizing FFR-Ct

9 Market Growth Enablers

9.1 New Technology Directions in FFR

9.2 Rising Patient Population of CVDS

9.3 Increasing Number of Cath Labs

10 Market Restraints

10.1 High Cost of FFR

10.2 Technical Limitations of FFR

10.3 Lower Adoption of FFR & Rise Of Substitutes

11 Market Landscape

11.1 Market Overview

11.2 Market Size & Forecast

11.2.1 Geography Insights

11.2.2 Technology Insights

11.2.3 Applications Insights

11.2.4 End-User Insights

11.3 Five Forces Analysis

11.3.1 Threat of New Entrants

11.3.2 Bargaining Power of Suppliers

11.3.3 Bargaining Power of Buyers

11.3.4 Threat of Substitutes

11.3.5 Competitive Rivalry

12 Technology

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Non-Invasive

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.3.3 Non-Invasive FFR by Geography

12.4 Invasive

12.4.1 Market Overview

12.4.2 Market Size & Forecast

12.4.3 Invasive FFR by Geography

13 Applications

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Single-Vessel

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.3.3 Single-Vessel FFR by Geography

13.4 Multi-Vessel

13.4.1 Market Overview

13.4.2 Market Size & Forecast

13.4.3 Multi-Vessel FFR by Geography

14 End-User

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Hospitals & Specialty Cardiac Centers

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.3.3 Hospitals & Specialty Cardiac Centers Segmentation by Geography

14.4 Office-Based Labs

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.4.3 Office-Based Labs FFR by Geography

14.5 Diagnostic Imaging Centers

14.5.1 Market Overview

14.5.2 Market Size & Forecast

14.5.3 Diagnostic Imaging Centers Segmentation by Geography

14.6 Others

14.6.1 Market Overview

14.6.2 Market Size & Forecast

14.6.3 Others Segmentation by Geography

Explore our healthcare lifesciences profile to know more about the industry.

Click Here to Download the Free Sample Report

Read some of the top-selling reports:

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Click Here to Contact Us

Call: +1-312-235-2040

+1 302 469 0707

Leave a Reply

Your email address will not be published.